
The Cancer Industry

When patients aren’t scared-to-death and rushed into treatment by their doctors, rates of spontaneous regression can be seen as high as 7% in renal carcinoma patients,[62] up to 15% in melanoma patients[63] and up to 20% in patients with low-grade lymphoma.[64] Some studies have recorded even higher rates of spontaneous regression.[65-68]
Mark Sloan • The Cancer Industry
A study published in the Journal of the American Medical Association in 2015 investigated the 20-year mortality rates of more than 108,196 women diagnosed with ductal carcinoma in situ. Results showed that 20-years after diagnosis, treated or not, only 3.3% of the women died of breast cancer.[37] The results of this study prompted Laura Esserman, M
... See moreMark Sloan • The Cancer Industry
Breast Cancer More than 60,000 women in the United States are diagnosed every year with a type of early-stage breast cancer called ductal carcinoma in situ (DCIS).[34] Between the years 1983 and 2003 there was a 500% increase in the number of women diagnosed with DCIS,[35] most of whom underwent damaging and unnecessary surgical procedures.[36] And
... See moreMark Sloan • The Cancer Industry
Cancer surgery: “The conclusion from the previous analysis, that surgery has not been shown to reduce mortality for any form of cancer, is therefore still valid.”
Mark Sloan • The Cancer Industry
Early detection: “No correlation was found between reduced breast cancer mortality and earlier surgical intervention. In fact, the trial with the most earlier surgical intervention had the smallest reduction in mortality; and that with the least earlier surgical intervention had the largest reduction in mortality. This demonstrates that the earlier
... See moreMark Sloan • The Cancer Industry
A 2012 study published in the New England Journal of Medicine concluded that one in three women (33%) diagnosed with breast cancer from a mammogram are misdiagnosed, and that a whopping 1.3 million women have been overdiagnosed by mammography in the past 30 years.[32]
Mark Sloan • The Cancer Industry
Over the course of 10 mammograms, women in the United States have between a 58-77% chance of being falsely diagnosed with breast cancer.[30] Another study found that for women with multiple breast cancer risk factors, like a strong family history, prolonged use of the contraceptive pill, etc. – the ones most strongly urged to have annual mammograms
... See moreMark Sloan • The Cancer Industry
Overdiagnosis and Overtreatment One of the major failures of mammography is how frequently it results in misdiagnosis of breast cancer.
Mark Sloan • The Cancer Industry
The 25-year combined follow-up of the Canadian National Breast Screening Study 1 and 2 was one of the largest and most meticulous studies ever conducted on mammography. Published in the British Medical Journal in 2014, results showed that “Annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical ex
... See more